Therapeutic Solutions International, Inc. (OTCMKTS:TSOI – Get Free Report) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Therapeutic Solutions International shares last traded at $0.00, with a volume of 182,924,719 shares changing hands.
Therapeutic Solutions International Stock Performance
Therapeutic Solutions International Company Profile
Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.
Featured Stories
- Five stocks we like better than Therapeutic Solutions International
- Pros And Cons Of Monthly Dividend Stocks
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- Dividend Capture Strategy: What You Need to Know
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- CD Calculator: Certificate of Deposit Calculator
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Therapeutic Solutions International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapeutic Solutions International and related companies with MarketBeat.com's FREE daily email newsletter.
